Purchase Order 75N92019P00032
Award Date 12/21/18
Potential Completion Date 12/20/20
Potential Value $200K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
La Jolla, CA 92037, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Sanford Burnham Prebys Medical Discovery Institute, a non-profit research organization. The $4,406.40 contract is for RNA extraction and microarray hybridization services. There is no set-aside designation for this contract. Sanford Burnham Prebys is an independent, non-profit research institute focused on...
- <p>The National Heart Lung and Blood Institute issued a $25,562.04 delivery order to Illumina, Inc. on May 11, 2018, for genetic sequencing and genomic analysis products.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- <p>The National Heart Lung and Blood Institute issued a $19,715.78 delivery order to Illumina, Inc. on December 9, 2026, for Illumina reagents and consumables.</p> <p>Place of performance is San Diego, California. The order is firm fixed price with no set-aside applied. Ultimate completion date is December 9, 2019.</p>
- <p>The National Heart Lung and Blood Institute issued a $139,090.77 delivery order to Illumina, Inc. on May 24, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. The delivery is priced on a firm fixed-price basis with no set-aside applied.</p>
- <p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on December 7, 2017, with a ceiling value of $96,730.28 for Illumina reagents and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of September 2, 2020.</p>
- <p>The National Heart, Lung and Blood Institute (NHLBI) issued a purchase order to Psomagen Inc. on May 14, 2026, valued at $199,994.72 for Olink Explore HT proteomic analysis supporting a sickle cell disease study. Work is performed in Rockville, Maryland, with an ultimate completion date of November 21, 2026. The purchase order is a firm fixed-price, severable contract with no set-aside designation.</p>
- <p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on May 3, 2019, with a ceiling value of $54,938.64 for the addition of $4.80 in funds to line item 1.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- <p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on November 28, 2018, with a ceiling value of $94,636.62 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed-price with ultimate completion by September 2, 2020. No set-aside was applied.</p>
- <p>The National Heart Lung and Blood Institute issued a $65,338.65 delivery order to Illumina, Inc. on February 19, 2019, for Illumina reagents and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price, with no set-aside applied.</p>
- <p>The National Heart Lung and Blood Institute issued a $1,582,411.88 delivery order to Illumina, Inc. on August 31, 2020, for Illumina reagents and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order has a completion date of September 2, 2020 and is priced on a firm fixed-price basis with no set-aside designation.</p>